跳至主要内容
临床试验/NCT01199510
NCT01199510已完成4 期

Efficacy Evaluation of SYSTANE® ULTRA in Patients Scheduled for Cataract Surgery

Alcon Research0 个研究点目标入组 40 人开始时间: 2010年9月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
40
主要终点
Ocular Comfort

研究概览

简要总结

The purpose of this study is to evaluate the effectiveness of FID 112903 (SYSTANE ULTRA® Lubricating Drops) plus standard of care to standard of care alone, in subjects with a history of intermittent eye irritation or dryness related to environmental factors and scheduled for routine cataract surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients must be at least 18 years of age
  • •Patients must be seeking routine cataract extraction with monofocal intraocular lens implantation

排除标准

  • •Patients for whom both eyes do not meet all inclusion criteria and either eye meets any exclusion criteria.
  • •Patients cannot have a history of hypersensitivity to any component of FID
  • •Patients cannot have previous intraocular or corneal surgery or any planned within 30 days.
  • •Patients cannot use any ocular medications other than test article and standard of care post-op medications in past 14 days or during study.
  • •Patients cannot be on chronic systemic corticosteroid or other immunosuppressive therapy.
  • •Patients cannot have a history of steroid-responsive rise in intraocular pressure, glaucoma, or preoperative Intraocular pressure >25 millimeters mercury in either eye.
  • •Patients cannot have a history and/or current evidence of the following: clinically significant corneal scarring, blepharitis or macular pathology in either eye, Herpes zoster or Herpes simplex keratitis.

研究组 & 干预措施

Standard of Care plus FID 112903

Experimental

SYSTANE® ULTRA Lubricant Eye Drops dosed 4 times daily

干预措施: FID 112903 (SYSTANE® ULTRA Lubricant Eye Drops) plus standard of care (Other)

Standard of Care only

Active Comparator

Post Cataract Standard of Care Regimen

干预措施: Standard of Care (Other)

结局指标

主要结局

Ocular Comfort

时间窗: 30 days

Ocular comfort will be reported by the patient on a questionnaire

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验